FDA Inspection 958740 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 3007075120

The FDA completed an inspection of New York Blood Center Enterprises on February 16, 2016 in Rockville Centre, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 16, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rockville Centre, NY (United States)